FC
DGX icon

FORA Capital’s Quest Diagnostics DGX Stock Holding History

FORA Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,273
Closed -$722K – 471
2024
Q2 		$722K Sell
5,273
-23,430
-82% -$3.21M 0.09% 253
2024
Q1 		$3.82M Buy
28,703
+6,831
+31% +$886K 0.31% 96
2023
Q4 		$3.02M Buy
21,872
+3,669
+20% +$482K 0.26% 113
2023
Q3 		$2.22M Buy
+18,203
New +$2.43M 0.19% 148
2023
Q2 		– Sell
-21,206
Closed -$3M – 410
2023
Q1 		$3M Buy
+21,206
New +$3.03M 0.3% 104
2022
Q3 		– Sell
-1,873
Closed -$249K – 444
2022
Q2 		$249K Sell
1,873
-8,179
-81% -$1.11M 0.05% 367
2022
Q1 		$1.4M Buy
+10,052
New +$1.4M 0.25% 121
2021
Q4 		– Sell
-6,468
Closed -$940K – 347
2021
Q3 		$940K Sell
6,468
-3,628
-36% -$531K 0.24% 128
2021
Q2 		$1.33M Buy
10,096
+7,727
+326% +$1.01M 0.25% 103
2021
Q1 		$304K Buy
+2,369
New +$292K 0.1% 226
2020
Q2 		– Sell
-2,208
Closed -$177K – 999
2020
Q1 		$177K Sell
2,208
-11,453
-84% -$1.19M 0.04% 480
2019
Q4 		$1.46M Buy
+13,661
New +$1.42M 0.15% 182

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

FORA Capital's DGX Position: Q3 2024 in Review

FORA Capital sold out of Quest Diagnostics (DGX) in Q3 2024, closing a stake of 5,273 shares — an estimated $722K sold.

FORA Capital first reported a position in DGX in Q4 2019 and held it in 12 quarters. The position peaked at $3.82M in Q1 2024. 847 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

  • FORA Capital reported no remaining Quest Diagnostics position as of Q3 2024 after selling out during the quarter.
  • FORA Capital sold 5,273 Quest Diagnostics shares in Q3 2024, an estimated $722K.
  • FORA Capital first reported a position in Quest Diagnostics in Q4 2019 and held it in 12 quarters.
  • FORA Capital's Quest Diagnostics position peaked at $3.82M in Q1 2024.
  • 847 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on FORA Capital's 13F filing for Q3 2024, filed 13 Nov 2024.